Dr. Alex Spyropoulos, MD

• Internal Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Hosp, Internal Medicine

  Residency Hospital

• University Of Pennsylvania Perelman School Of Medicine

  Medical School, 1992

• Rivaroxaban Plus Aspirin for Extended Thromboprophylaxis in Acutely Ill Medical Patients: Insights from the MARINER Trial, 2022-07-11

• New Paradigms of Extended Thromboprophylaxis in Medically Ill Patients, 2020-04-02

• Prognostic Value of Venous Thromboembolism Risk Assessment Models in Patients with Severe COVID-19, 2021-06-22

• Modified IMPROVE VTE Risk Score and Elevated D-Dimer Identify a High Venous Thromboembolism Risk in Acutely Ill Medical Population for Extended Thromboprophylaxis, 2020-03-13

• Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study, 2019-11-20

• Extended Thromboprophylaxis in Hospitalized Patients with Heart Failure: A Post Hoc Analysis of the MAGELLAN Study, 2022-10-07

• Effect of Direct Oral Anticoagulant, Patient, and Surgery Characteristics on Clinical Outcomes in the Perioperative Anticoagulation Use for Surgery Evaluation Study, 2020-09-23

• Occurrence of Thromboembolic Events and Mortality Among Hospitalized Coronavirus 2019 Patients: Large Observational Cohort Study of Electronic Health Records, 2022-11-18

• Identification and Outcomes of Hospitalized Medically Ill Patients Who Are Candidates for Extended Duration Thromboprophylaxis, 2020-10-31

• Immunomodulation and Reduction of Thromboembolic Risk in Hospitalized COVID-19 Patients: Systematic Review and Meta-Analysis of Randomized Trials, 2021-11-18